At the end of each year, members of the American Journal of Psychiatry (AJP) Editorial Board select the studies they found particularly impactful in the previous 12 months. The nine studies selected for 2022 have expanded the understanding of the impact of stress hormones on brain development, revealed new insights into how and when the brains of infants who go on to develop autism diverge from their peers, exposed the long-term cognitive effects of cannabis use, and more.
“There were outstanding papers selected this year that showcase some of the cutting-edge tools and ideas … in psychiatry,” said Ned Kalin, M.D., AJP editor-in-chief and the Hedberg Professor and Chair of Psychiatry at the University of Wisconsin School of Medicine and Public Health.
Kalin’s selection was the study that utilized brain organoids to assess how stress hormones, such as cortisol, affect brain development. “We know that early life stress is a very large risk factor for psychiatric illness later in life,” he said. “Cerebral organoids are like living test tubes that enable researchers to recreate these aspects of these early life stressors and observe how developing neurons are impacted.”
Other 2022 editors’ picks included the following:
To learn more about these and the other selected studies, see the Psychiatric News article “2022 AJP Editors’ Picks Showcase Innovation, Long-Term Studies” and the AJP article “2022 Articles of Import and Impact.”
APA invites all APA voting members to participate in its 2023 election. Please take the time to learn about the candidates and cast your ballot. Your vote has an impact on the future of APA and psychiatry.